🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is studying an investigational drug, NC318, as a possib...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-06
Trial ID
NCT04430933
Treatments Being Tested
This multicentre, randomized controlled trial evaluates the effect and safe...
Status
Recruiting
Location
Guangdong Provincial Hospital of Chinese Medicine
Start Date
2026-01-15
Trial ID
NCT07337096
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
A first in human study to evaluate the safety and preliminary antitumor act...
Status
Recruiting
Location
The Angeles Clinic and Research Institute - West Los Angeles Office
Start Date
2025-03-31
Trial ID
NCT06917079
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
The purpose of this study is to assess the efficacy and safety of platinum-...
Status
Completed
Location
Pacific Cancer Medical Center
Start Date
2020-09-11
Trial ID
NCT04205812
Treatments Being Tested
The purpose of this study is to determine the efficacy of nab-paclitaxel mo...
Status
Unknown
Location
Cancer institute and hospital, Chinese Academy of Medical Sciences
Start Date
2013-09
Trial ID
NCT01969955
Treatments Being Tested
In this study circulating tumor DNA (ctDNA) blood testing is used to detect...
Status
Suspended
Location
Stanford University
Start Date
2021-04-08
Trial ID
NCT04585477
This is an open label, randomized, Phase II multicenter study designed to e...
Status
Withdrawn
Location
Asklepios Fachkliniken München-Gauting
Start Date
2022-05-20
Trial ID
NCT05383001
Treatments Being Tested